Pathos AI nabs $62M Se­ries C as it hunts for more Phase 1 drugs with AI

6 months ago
Financing
AI

Paragon launch­es an­oth­er com­pa­ny in hot PD-1xVEGF space that goes straight to re­verse merg­er

6 months ago
Deals

Up­dat­ed: Pfiz­er’s Covid pill pow­ers guid­ance raise, but short­fall else­where rais­es ques­tions

6 months ago
Pharma

Cor­rect­ed: Gen­mab lines up T cell en­gager pact with Re­vi­tope

6 months ago
Startups
Deals

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

6 months ago
Deals
R&D

Iambic at­tempts to ‘break the wall’ be­tween the lab and clin­ic with new AI mod­el

6 months ago
AI

#HLTH24: How Nvidia plans to pro­vide the build­ing blocks of AI in health tech

6 months ago
AI
Health Tech

WuXi AppTec is still sign­ing on new clients de­spite Biose­cure threat

6 months ago
China
Manufacturing

Pfiz­er’s make-or-break quar­ter

6 months ago
Editor's note
Pharma

Bi­par­ti­san let­ter ques­tions FDA's 'nar­row' in­ter­pre­ta­tion for pri­or­i­ty re­view vouch­ers

6 months ago
Pharma
FDA+

Await­ing ex­pand­ed ap­provals, Lil­ly and J&J re­lease late-stage da­ta for Crohn's treat­ments

6 months ago
R&D
Pharma

BeiGene ex­ec­u­tive re­port­ed­ly un­der in­ves­ti­ga­tion in Chi­na

6 months ago
China
Pharma

Bio­gen's full Ph2 da­ta for IgA nephropa­thy drug; Sanofi in­vests in obe­si­ty biotech

6 months ago
News Briefing

Ab­b­Vie makes $1.4B ac­qui­si­tion of Alzheimer's biotech

6 months ago
Startups
Deals

HOPO Ther­a­peu­tics wins up to $226M BAR­DA con­tract for heavy met­al poi­son­ing re­search

6 months ago
R&D

Synaf­fix, in­dus­try's ADC part­ner of choice, spins out a start­up pipeline

6 months ago
Financing
Startups

For­mer Seagen CEO David Ep­stein to lead new biotech with VEGF bi­func­tion­al an­ti­body

6 months ago
Startups
R&D

Fog­Phar­ma re­brands as Para­bilis Med­i­cines, as CEO Math­ai Mam­men high­lights next drugs

6 months ago
Startups
R&D

No­var­tis pays Monte Rosa $150M for Phase 1 drug in lat­est en­dorse­ment of mol­e­c­u­lar glues

6 months ago
Deals

Lat­est sal­vo in Pfiz­er ac­tivist fight; John Car­rol­l's Q3 biotech roundup; In­tel­lia un­veils CRISPR re­sults; and more

6 months ago
Weekly

Rev­o­lu­tion Med­i­cines breaks ground in chal­leng­ing pan­cre­at­ic can­cer with two RAS drugs

6 months ago
R&D

Hun­gary's Olivér Várhe­lyi read­ies to be EU health com­mis­sion­er, pledg­ing ma­jor phar­ma sup­port

6 months ago
Pharma
Law

House Re­pub­li­cans push for more trans­paren­cy on gov­ern­ment-fund­ed tri­al da­ta

6 months ago
Pharma
FDA+

Iterum wins ap­proval for new oral an­tibi­ot­ic for UTIs. Now it wants a part­ner

6 months ago
Pharma
FDA+
First page Previous page 73747576777879 Next page Last page
A service from the Financial Times